The battery life of implantable heart monitors must be improved to reduce the need for replacement and the risks this carries for patients, argue two senior doctors in The BMJ today.
Feb 4, 2016
0
1
Patients with moderate-to-severe chronic kidney disease who received cardiac resynchronization therapy with defibrillator had a lower risk of hospitalization for heart failure or death from this condition compared to patients ...
Dec 7, 2015
0
11
When people with end-stage kidney disease start dialysis, a treatment that filters the blood to rid the body of harmful waste, extra salt and water, they are at high risk of sudden cardiac death. Researchers at the University ...
Oct 8, 2015
0
11
Heart failure patients whose implantable cardioverter defibrillators (ICDs) include an automated alert when too much fluid accumulates in their lungs did not have improved outcomes compared to patients with regular ICDs, ...
Sep 1, 2015
0
5
Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the first time today at ESC ...
Sep 1, 2015
0
13
A gene associated with sudden cardiac death in the general population has been identified using implantable cardioverter defibrillator (ICD) monitoring in research presented for the first time at ESC Congress today. The research ...
Aug 31, 2015
0
8
ESC Guidelines published today recommend DNA analysis as a fundamental component of post mortem assessment in young sudden death victims. Identification of a genetic cause helps to quickly diagnose and protect relatives.
Aug 29, 2015
0
6
Sports participation may be safer than previously thought for children with the heart rhythm disorder long QT syndrome, and authors of a new study in JACC: Clinical Electrophysiology say restrictions should be eased to allow ...
Apr 20, 2015
0
8
Racial and ethnic minorities who receive implantable devices to treat heart failure derive the same substantial survival benefit from these therapies as white patients, new UCLA-led research shows.
Aug 18, 2014
0
0
Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according ...
Jun 3, 2014
0
0
